{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:04:37Z","timestamp":1758125077569},"reference-count":36,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.135","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T18:05:21Z","timestamp":1437588321000},"page":"135-141","source":"Crossref","is-referenced-by-count":5,"title":["The pathogenic role of macrophage in lupus nephritis"],"prefix":"10.2177","volume":"38","author":[{"given":"Masafumi","family":"SUGIYAMA","sequence":"first","affiliation":[{"name":"Department of Nephrology Hashima Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"KINOSHITA","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Kinki University Sakai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"FUNAUCHI","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Internal Medicine Kinki University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"2) Hiramatsu, N., et al.: Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. <i>Rheumatology<\/i>. <b>47<\/b>: 702-707, 2008."},{"key":"2","unstructured":"3) Hill, G.S., et al.: Predictive power of the second renal biopsy in lupus nephritis: significance of macrophage. <i>Kidney Int.<\/i> <b>59<\/b>: 304-316, 2001."},{"key":"3","unstructured":"4) Alexopoulous, E., et al.: Lupus nephritis: Correlation of interstitial cells with glomerular function. <i>Kidney Int.<\/i> <b>37<\/b>: 100-109, 1990."},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Giannico, G., Fogo, A.B.: Lupus nephritis: Is the kidney biopsy currently necessary in the management of lupus nephritis? <i>Clin J Am Soc Nephrol.<\/i> <b>8<\/b>: 138-145, 2013.","DOI":"10.2215\/CJN.03400412"},{"key":"5","unstructured":"6) Magil, A.B., et al.: Monocyte and human renal glomerular diseases: a quantitative evaluation. <i>Lab Invest.<\/i> <b>44<\/b>: 27-33, 1981."},{"key":"6","unstructured":"7) Stephen, R., et al.: Wilson. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit use of an antimacrophage serum. <i>J Clin Invest.<\/i> <b>68<\/b>: 686-698, 1981."},{"key":"7","unstructured":"8) Holdworth, S.R., Neale, T.J.: Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis. <i>Lab Invest.<\/i> <b>51<\/b>: 172-180, 1984."},{"key":"8","unstructured":"9) Ter Borg, E.J., et al.: Predictive value of rises in anti-double-stranded DNA antibody levels for diseases exacerbation in systemic lupus erythematosus: a long term prospective study. <i>Arthritis Rheum.<\/i> <b>33<\/b>: 634-643, 1990."},{"key":"9","unstructured":"10) Winfield, J.B., et al.: Avidity of anti-DNA Antibodies in serum and IgG glomerula eluates from patients with systemic lupus erythematosus. <i>J Clin Invest.<\/i> <b>59<\/b>: 90-96, 1977."},{"key":"10","unstructured":"11) Shlomchik, M.J., et al.: The role of B cells in Lpr\/lpr-induced autoimmunity. <i>J Exp Med.<\/i> <b>180<\/b>: 1295-1396, 1994."},{"key":"11","unstructured":"12) Owen, T.M., et al.: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. <i>J Exp Med.<\/i> <b>189<\/b>: 1639-1647, 1999."},{"key":"12","unstructured":"13) Alexopoulous, E., et al.: Lupus nephritis: Correlation of interstitial cells with glomerular function. <i>Kidney Int.<\/i> <b>37<\/b>: 100-109, 1990."},{"key":"13","unstructured":"14) Schiffer, L., et al.: Activated renal macrophage are markers of disease onset and disease remission in lupus nephritis. <i>J Immunol.<\/i> <b>180<\/b>: 1938-1947, 2008."},{"key":"14","unstructured":"15) Ikezumi, Y., et al.: The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. <i>Nephrol Dial Transplant.<\/i> <b>20<\/b>: 2704-2713, 2005."},{"key":"15","unstructured":"16) Wada, T., et al.: Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. <i>Kidney Int.<\/i> <b>49<\/b>: 761-767, 1996."},{"key":"16","unstructured":"17) Tesch, G.H., et al.: Monocyte chemoattractant protein1-dependent leukocytic infiltrates are responsible for autoimmune diseasein MRL-Fas lpr mice. <i>J Exp Med.<\/i> <b>190<\/b>: 1813-1824, 1999."},{"key":"17","unstructured":"18) Shimizu S., et al.: Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL\/lpr mice. <i>Rheumatology.<\/i> <b>43<\/b>: 1121-1128, 2004."},{"key":"18","unstructured":"19) Hasegawa, H., et al.: Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL\/lpr mice. <i>Arthritis and Rheum.<\/i> <b>48<\/b>: 2555-2566, 2003."},{"key":"19","unstructured":"20) Lema, G.P., et al.: Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL\/lpr lupus-prone mice. <i>J Am Soc Nephrol.<\/i> <b>16<\/b>: 3592-3601, 2005."},{"key":"20","unstructured":"21) Kaufmann, A., et al.: Increase of CCR1 and CCR5 expression and enhanced of human monocytes to macrophages. <i>J Leukoc Biol.<\/i> <b>69<\/b>: 248-252, 2001."},{"key":"21","unstructured":"22) Lema, G.P., et al.: Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and chemokine expression during the initiation of murine lupus nephritis. <i>J Am Soc Nephrol.<\/i> <b>12<\/b>: 1369-1382, 2001."},{"key":"22","unstructured":"23) Anders, H.-J., et al.: Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of Lupus Nephritis in MRL-Fas(lpr) mice. <i>J Am Soc Nephrol.<\/i> <b>15<\/b>: 1504-1513, 2004."},{"key":"23","unstructured":"24) Tian, S., et al.: Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare. <i>Inflamm Res.<\/i> <b>56<\/b>: 304-310, 2007."},{"key":"24","unstructured":"25) Menke, J., et al.: Colony-stimulating factor-1: A potential biomarker for lupus nephrits. <i>J Am Soc Nephrol.<\/i> <b>26<\/b>: 379-389, 2015."},{"key":"25","unstructured":"26) Lenda, D.M. et al.: Negative role of colony-stimulating factor-1 in macrophage, T cell and B cell mediated autoimmune disease in MRL-Fas lpr mice. <i>J Immunol.<\/i> <b>173<\/b>: 4744-4754, 2004."},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Wang, Y., Harris D.C.H.: Macrophage in Renal Disease. <i>J Am Soc Nephrol.<\/i> <b>22<\/b>: 21-28, 2011.","DOI":"10.1681\/ASN.2010030269"},{"key":"27","unstructured":"28) Wang, Y., et al.: Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. <i>Kidney Int.<\/i> <b>72<\/b>: 290-299, 2007."},{"key":"28","unstructured":"29) Cao, Q., et al.: IL-10\/TGF-beta-modified macrophages induce regulatory T cells and protect against murine Adriamycin nephrosis. <i>J Am Soc Nephrol.<\/i> <b>21<\/b>: 939-942, 2010."},{"key":"29","unstructured":"30) Bingon, A., et al.: CCR1 inibition ameliorates the progression of Lupus nephritis in NZB\/W mice. <i>J Immunol.<\/i> <b>192<\/b>: 886-896, 2014."},{"key":"30","unstructured":"31) Bethunaickan, R., et al.: A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. <i>J Immunol.<\/i> <b>186<\/b>: 4994-5003, 2011."},{"key":"31","unstructured":"32) Zizzo, G., et al.: Circulating levels of soluble MER in lupus reflect M2c activation of monocyte\/macrophages, autoantibody specificities and disease activity. <i>Arthritis Res ther.<\/i> <b>15<\/b>: R212, 2013."},{"key":"32","unstructured":"33) Kulkarni, O., et al.: Spiegelmer inhibition of CCL2\/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. <i>J Am Soc Nephrol.<\/i> <b>18<\/b>: 2350-2358, 2007."},{"key":"33","unstructured":"34) Han, Y., et al.: c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. <i>Lab invest.<\/i> <b>91<\/b>: 978-991, 2011."},{"key":"34","unstructured":"35) Chalmers, S.A., et al.: Macrophage depletion ameliorates nephritis induced by pathogenic antibodies. <i>J Autoimmun.<\/i> <b>57<\/b>: 42-52, 2015."},{"key":"35","unstructured":"36) Kyriakis, J.M., Avruch, J.: Mammmalian mitogen-activated protein kinase signal transduction pathway activated by stress and inflammation. <i>Physiol Rev.<\/i> <b>81<\/b>: 807-869, 2001."},{"key":"36","unstructured":"37) Flanc, R.S., et al.: A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis. <i>Kidney Int.<\/i> <b>72<\/b>: 698-708, 2007."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u30eb\u30fc\u30d7\u30b9\u814e\u708e\u306b\u304a\u3051\u308b\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306e\u5f79\u5272"],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:12:44Z","timestamp":1498219964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/3\/38_135\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.135","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}